Taiwan's NHI To Cover Cost Of $82-A-Pill MS Drug For 1,117 Patients
This article was originally published in PharmAsia News
Executive Summary
Taiwan's Bureau of National Health Insurance decided to cover much of the cost of a multiple sclerosis drug that costs so much that most of the nation's 1,117 patients cannot afford it.